Bleeding with menopausal hormone therapy.

Area of Science:

• Gynecology
• Endocrinology
• Reproductive Medicine

Background:

• Hormone therapy (HT) effectively manages menopausal vasomotor symptoms and vaginal dryness.
• Unscheduled vaginal bleeding is a common and unpopular side effect of HT.
• Current investigations for bleeding often involve invasive procedures, frequently yielding no pathological findings.

Purpose of the Study:

• To investigate the poorly understood mechanisms of endometrial breakdown and bleeding induced by combined hormone therapy.
• To explore how hormone therapy affects endometrial vasculature and stroma.
• To differentiate bleeding mechanisms in HT users from normal menstruation and progestogen-only contraceptive users.

Main Methods:

• Review of existing literature on hormone therapy and endometrial bleeding.
• Analysis of studies examining endometrial vascular changes (density, distribution, structure) under HT.
• Investigation of stromal alterations and vasoactive mediator production in response to HT.

Main Results:

• Hormone therapy exposure alters endometrial vessel density, distribution, and structure.
• Changes in the endometrial stroma may increase the production of vasoactive mediators.
• The bleeding mechanisms associated with HT appear distinct from normal menstruation.

Conclusions:

• Irregular bleeding during hormone therapy is likely due to specific endometrial vascular and stromal changes.
• Understanding these mechanisms can help improve patient adherence and reduce unnecessary investigations.
• Further research is needed to fully elucidate the pathways leading to hormone therapy-induced bleeding.